Anti-VEGF drugs such as bevacizumab, aflibercept, and ranibizumab are currently in use, as are steroids such as triamcinolone acetonide and dexamethasone implants, all of which are effective in the treatment of macular edema [10–12]. The gene discussed is VEGFA; the disease is macular retinal edema.